New Injury-Free Migraine Model Reveals How CGRP Receptor Activation Causes Migraine Pain Over Time
A novel injury-free "two-hit" mouse migraine model revealed distinct temporal contributions of CGRP receptor activation in migraine-like pain, with both acute sumatriptan treatment and preventive anti-CGRP antibody showing efficacy.
Quick Facts
What This Study Found
Novel injury-free two-hit hyperalgesic priming model produced CGRP-dependent migraine-like pain in mice. Sumatriptan (acute) and anti-CGRP antibody (preventive) both showed efficacy. CGRP receptor activation had distinct temporal contributions to pain phases. Sex differences observed.
Key Numbers
3-day stress priming; 16-day latent sensitization; olcegepant preventive but not acute; sumatriptan acute but not preventive; nor-BNI prevented priming
How They Did This
Animal study. C57BL/6 mice (male and female). Two-hit priming (CGRP exposure) + subthreshold TRPA1 challenge (umbellulone). Cutaneous allodynia and grimace measurements. Sumatriptan and anti-CGRP antibody treatment. Temporal analysis of CGRP contribution.
Why This Research Matters
Better migraine models lead to better drugs. This injury-free model more closely mimics human migraine vulnerability and revealed that CGRP plays different roles at different time points — information that could optimize the timing of anti-CGRP treatments.
The Bigger Picture
Migraine research needs models that reflect the disease's episodic, vulnerability-based nature. This model's ability to test both acute and preventive treatments and reveal sex differences makes it valuable for developing next-generation migraine therapies.
What This Study Doesn't Tell Us
Mouse model — migraine experience in humans is more complex. TRPA1 trigger may not represent all migraine triggers. Sex differences in mice may not match human sex differences. Model validation against clinical endpoints limited.
Questions This Raises
- ?Does the temporal pattern of CGRP contribution match the clinical time course of migraine attacks?
- ?Could this model identify the optimal dosing schedule for anti-CGRP preventive treatments?
- ?Do sex differences in the model explain why migraine is 3x more common in women?
Trust & Context
- Key Stat:
- Injury-free migraine model First preclinical migraine model that produces CGRP-dependent pain without tissue injury — more accurately reflecting how human migraines develop
- Evidence Grade:
- Moderate evidence: well-characterized animal model validated with established migraine drugs. Novel translational approach.
- Study Age:
- Published 2021. Advanced migraine models incorporating vulnerability priming are being adopted by the field.
- Original Title:
- A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
- Published In:
- Cephalalgia : an international journal of headache, 41(3), 305-317 (2021)
- Authors:
- Kopruszinski, Caroline M(2), Navratilova, Edita(4), Swiokla, Juliana, Dodick, David W, Chessell, Iain P, Porreca, Frank
- Database ID:
- RPEP-05508
Evidence Hierarchy
Frequently Asked Questions
Why is an injury-free model important for migraine?
Most animal pain models involve cutting or injuring tissue, but migraines aren't caused by injuries. This model creates migraine-like vulnerability through prior CGRP exposure — similar to how repeated migraines sensitize the human brain to future attacks.
Does this change how we think about CGRP in migraines?
Yes — it shows CGRP doesn't just trigger pain at one moment but contributes differently at different time points during a migraine attack. This could explain why some patients respond better to acute versus preventive anti-CGRP treatments.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05508APA
Kopruszinski, Caroline M; Navratilova, Edita; Swiokla, Juliana; Dodick, David W; Chessell, Iain P; Porreca, Frank. (2021). A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.. Cephalalgia : an international journal of headache, 41(3), 305-317. https://doi.org/10.1177/0333102420959794
MLA
Kopruszinski, Caroline M, et al. "A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.." Cephalalgia : an international journal of headache, 2021. https://doi.org/10.1177/0333102420959794
RethinkPeptides
RethinkPeptides Research Database. "A novel, injury-free rodent model of vulnerability for asses..." RPEP-05508. Retrieved from https://rethinkpeptides.com/research/kopruszinski-2021-a-novel-injuryfree-rodent
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.